Saturday, October 31, 2026

Meta locks in nuclear power across three deals as global AI infrastructure chase intensifies

Meta signed three nuclear energy agreements on January 1, 2026, joining tech giants worldwide racing to secure dedicated power for AI data centers that consume 100+ megawatts each. The move reflects a global shift as companies from Silicon Valley to Asia treat electricity access as competitive infrastructure, not a commodity input.

ViaNews Editorial Team

February 23, 2026

Meta locks in nuclear power across three deals as global AI infrastructure chase intensifies
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Meta signed three nuclear energy deals on January 1, 2026, part of a global scramble by AI companies to lock down power for data centers running inference and training workloads that can consume more than 100 megawatts—enough to power 80,000 homes.

The Trump administration announced an AI power initiative the same day, while DMG disclosed December 4, 2025 it's pursuing energy partnerships for its Christina Lake AI facility. Westinghouse secured a U.S. government contract for reactor deployment, and GE Vernova raised financial guidance December 9, 2025 as investors bet energy infrastructure will capture AI buildout value.

Nuclear power delivers advantages critical for 24/7 AI operations: constant output regardless of weather, compact land footprint versus solar farms, and no battery storage needed for intermittency. Data centers require uninterrupted supply with minimal voltage fluctuation, making coal and gas less viable as tech firms pursue decarbonization targets.

The pattern extends beyond U.S. borders. China's AI labs are co-locating facilities near hydroelectric and nuclear plants, while European hyperscalers face grid constraints that limit deployment speed. Energy capacity, not chip supply, may become the binding constraint on global AI expansion through 2027.

Nuclear energy stocks have tracked AI infrastructure announcements over six months, with market participants pricing sustained demand. Companies now allocate capital expenditures to power infrastructure at unprecedented rates, treating electricity as a competitive moat.

Tech giants face a choice: build near existing power sources, fund new generation capacity, or accept limits on model scale and deployment. Meta's deals signal the largest players are choosing dedicated infrastructure over grid dependence—a template likely to spread as AI workloads scale globally.


Sources:
1 Globe Newswire, "DMG Blockchain Solutions Announces 75 MW Utility Approval Expanding Christina Lake Data Center Power" (March 06, 2026)
2 Yahoo Finance, "Cenovus Energy’s Christina Lake Expansion Reshapes Growth And Valuation Story" (March 04, 2026)
3 Yahoo Finance, "Oklo (OKLO) Stock Up After Jim Cramer Called It Speculative" (March 21, 2026)
4 Yahoo Finance, "Jim Cramer on GE Vernova: “It’s Just Got the Best Book of Business”" (March 21, 2026)
5 Yahoo Finance, "Asian shares decline as hopes dim for resolution in Iran after Trump's latest comments" (March 23, 2026)

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com